| Authors: |
Button JE; Prolacta Bioscience, Duarte, CA 91010, USA., Cosetta CM; Prolacta Bioscience, Duarte, CA 91010, USA., Reens AL; Prolacta Bioscience, Duarte, CA 91010, USA., Brooker SL; Prolacta Bioscience, Duarte, CA 91010, USA., Rowan-Nash AD; Prolacta Bioscience, Duarte, CA 91010, USA., Lavin RC; Prolacta Bioscience, Duarte, CA 91010, USA., Saur R; Prolacta Bioscience, Duarte, CA 91010, USA., Zheng S; Prolacta Bioscience, Duarte, CA 91010, USA., Autran CA; Prolacta Bioscience, Duarte, CA 91010, USA., Lee ML; Prolacta Bioscience, Duarte, CA 91010, USA; Department of Biostatistics, University of California Los Angeles, Fielding School of Public Health, Los Angeles, CA 90095, USA., Sun AK; Prolacta Bioscience, Duarte, CA 91010, USA., Alousi AM; Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA., Peterson CB; Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., Koh AY; Department of Pediatrics, Division of Hematology/Oncology, The University of Texas Southwestern Medical Center, Dallas, TX 75235, USA; Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Microbiology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Rechtman DJ; Prolacta Bioscience, Duarte, CA 91010, USA., Jenq RR; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA., McKenzie GJ; Prolacta Bioscience, Duarte, CA 91010, USA. Electronic address: gmckenzie@prolacta.com. |